List of Chapters/Sections(Table Of Content)
1 Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Radiopharmaceuticals Segment by Type
1.2.1 Global Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Radiopharmaceuticals Segment by Application
1.3.1 Global Radiopharmaceuticals Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceuticals Revenue 2016-2027
1.4.2 Global Radiopharmaceuticals Sales 2016-2027
1.4.3 Radiopharmaceuticals Market Size by Region: 2016 Versus 2021 Versus 2027
2 Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
2.2 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Radiopharmaceuticals Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Radiopharmaceuticals Players Market Share by Revenue
2.5.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Radiopharmaceuticals Sales by Country
3.3.2 North America Radiopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Radiopharmaceuticals Sales by Country
3.4.2 Europe Radiopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Radiopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Radiopharmaceuticals Sales by Country
3.6.2 Latin America Radiopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Radiopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.2 Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.3 Global Radiopharmaceuticals Price by Type (2016-2021)
5 Global Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.2 Global Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.3 Global Radiopharmaceuticals Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Radiopharmaceuticals Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Description and Business Overview
6.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nordion Radiopharmaceuticals Product Portfolio
6.4.5 Nordion Recent Developments/Updates
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Description and Business Overview
6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
6.5.5 Triad Isotopes Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lantheus Radiopharmaceuticals Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 IBA Group
6.6.1 IBA Group Corporation Information
6.6.2 IBA Group Description and Business Overview
6.6.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 IBA Group Radiopharmaceuticals Product Portfolio
6.7.5 IBA Group Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Description and Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
6.9.5 China Isotope & Radiation Recent Developments/Updates
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Description and Business Overview
6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
6.10.5 Jubilant Pharma Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Radiopharmaceuticals Description and Business Overview
6.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Description and Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
6.12.5 Advanced Accelerator Applications Recent Developments/Updates
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Radiopharmaceuticals Description and Business Overview
6.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
6.13.5 SIEMENS Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Radiopharmaceuticals Description and Business Overview
6.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Radiopharmaceuticals Description and Business Overview
6.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Navidea Radiopharmaceuticals Product Portfolio
6.15.5 Navidea Recent Developments/Updates
7 Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radiopharmaceuticals
7.4 Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radiopharmaceuticals Distributors List
8.3 Radiopharmaceuticals Customers
9 Radiopharmaceuticals Market Dynamics
9.1 Radiopharmaceuticals Industry Trends
9.2 Radiopharmaceuticals Growth Drivers
9.3 Radiopharmaceuticals Market Challenges
9.4 Radiopharmaceuticals Market Restraints
10 Global Market Forecast
10.1 Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radiopharmaceuticals by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Radiopharmaceuticals by Type (2022-2027)
10.2 Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radiopharmaceuticals by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Radiopharmaceuticals by Application (2022-2027)
10.3 Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radiopharmaceuticals by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Radiopharmaceuticals by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
